The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience
- PMID: 17459663
- DOI: 10.1016/j.ijantimicag.2007.02.017
The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience
Abstract
In an attempt to define the most important driver responsible for recurrence of cystitis in women, 181 records were retrospectively analysed among 1010 consecutive references in a tertiary centre for lower urinary tract infections (UTIs). All 181 women had more than three episodes of cystitis per year; 129 were under continuous prophylaxis and 52 were under postcoital prophylaxis. Analysis revealed that the most important factor affecting successful outcome of chemoprophylaxis was the compliance of patients (odds ratio 0.074; P<0.0001). Among women treated for >or=6 months, the most effective regimen was nitrofurantoin, with a success rate of 96.8% compared with 82.8% for trimethoprim/sulphamethoxazole and 72.3% for norfloxacin (P=0.046 between agents). Failure of chemoprophylaxis was observed in 51 women in total; in 26 of them resistance to the administered agent had developed. Results of this retrospective study revealed that the most important driver leading to failure of prophylaxis for recurrent lower UTIs was the lack of compliance of women with their medication. Nitrofurantoin was the most potent among the administered agents.
Similar articles
-
Cystitis cystica and recurrent urinary tract infections in children.Coll Antropol. 2010 Sep;34(3):893-7. Coll Antropol. 2010. PMID: 20977079
-
Antimicrobial prophylaxis in women with recurrent urinary tract infections.Int J Antimicrob Agents. 2011 Dec;38 Suppl:36-41. doi: 10.1016/j.ijantimicag.2011.09.005. Epub 2011 Nov 4. Int J Antimicrob Agents. 2011. PMID: 22055655 Review.
-
Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.Pediatrics. 2008 Dec;122(6):1212-7. doi: 10.1542/peds.2007-2926. Pediatrics. 2008. PMID: 19047236
-
Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.Q J Med. 1991 Oct;81(294):811-20. Q J Med. 1991. PMID: 1801054 Clinical Trial.
-
Recurrent cystitis in nonpregnant women.West J Med. 1999 May;170(5):274-7. West J Med. 1999. PMID: 10379218 Free PMC article. Review.
Cited by
-
Formulation development and stability studies of norfloxacin extended-release matrix tablets.Biomed Res Int. 2013;2013:716736. doi: 10.1155/2013/716736. Epub 2013 Sep 8. Biomed Res Int. 2013. PMID: 24083235 Free PMC article.
-
[Primary vesicoureteral reflux].Urologe A. 2013 Jan;52(1):39-47. doi: 10.1007/s00120-012-3079-z. Urologe A. 2013. PMID: 23296463 German.
-
In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections.Infect Dis Ther. 2015 Dec;4(4):425-32. doi: 10.1007/s40121-015-0089-3. Epub 2015 Sep 21. Infect Dis Ther. 2015. PMID: 26391612 Free PMC article.
-
Contemporary management of uncomplicated urinary tract infections.Drugs. 2008;68(9):1169-205. doi: 10.2165/00003495-200868090-00002. Drugs. 2008. PMID: 18547131 Review.
-
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.Int Urogynecol J. 2014 Sep;25(9):1173-8. doi: 10.1007/s00192-013-2318-1. Epub 2014 Feb 20. Int Urogynecol J. 2014. PMID: 24554302 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical